Immune checkpoint inhibitor-induced colitis with endoscopic evaluation in Chinese cancer patients: a single-centre retrospective study

Immune checkpoint inhibitor-induced colitis with endoscopic evaluation in Chinese cancer patients: a single-centre retrospective study

BackgroundWe investigated the clinical and endoscopic features, management strategies, and outcomes of Chinese cancer patients with immune checkpoint inhibitor (ICI)-induced colitis.MethodThis single-centre retrospective study included patients who developed ICI-induced colitis and underwent endosco...

Täydet tiedot

Bibliografiset tiedot
Päätekijät: Furong Kou, Jian Li, Yanshuo Cao, Zhi Peng, Ting Xu, Lin Shen, Jifang Gong, Xicheng Wang
Aineistotyyppi: Artikkeli
Kieli:English
Julkaistu: Frontiers Media S.A. 2023-11-01
Sarja:Frontiers in Oncology
Aiheet:
immune checkpoint inhibitor
colitis
endoscopy
steroid
infliximab
rechallenge
Linkit:https://www.frontiersin.org/articles/10.3389/fonc.2023.1285478/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2023.1285478/full

Samankaltaisia teoksia